Dear Molecular Imaging Insider,
In Parkinson's disease, clinical presentations are heterogeneous, which means that patients’ symptoms can vary widely. FDG-PET brain scans can help in these cases by providing precise and accurate information.
Well-respected senior Argentinian radiologists have shared their experiences in this field, including four clinical figures. You can find out more in today’s top story.
PET imaging has also cast new light on how the consumption of ultraprocessed meals can lead to changes in the myocardial blood flow of healthy subjects.
The main goal of CLAUD-IT is to improve the overall quality and safety of radiology and nuclear medicine procedures through justification and optimization. This EU project is developing a training program for auditors, including guidelines and supporting documents, and it has just developed its first clinical audit guideline for nuclear medicine.
Engineered stone silicosis is an interstitial lung disease that progresses rapidly, and in many cases, it can cause respiratory insufficiency and death. Spanish researchers have used PET to find out more about the metabolic activities caused by this disease.
Meanwhile, a team from Dublin has found that reducing average injected dose and uptake time in prostate-specific membrane antigen PET/CT can lead to improved patient throughput, as well as boost patient access to this technique.
Looking ahead, the annual meeting of the European Association of Nuclear Medicine (EANM) begins in Barcelona on 4 October. Ahead of the congress, the dedicated webpages and submission platforms for the two journals owned by EANM have gone live.
These news stories are just a sample of the material we’ve posted during the last couple of months in the Molecular Imaging Content Area.
Philip Ward
Editor in Chief
AuntMinnieEurope.com